Abigail Voss
Primary Care · Los Angeles, CANPI 1013284934
Payments from drug & device makers
Across 70 payments — averaging $22.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$190
- Radius Health, Inc.$178
- AbbVie$142
- Boehringer Ingelheim$140
- Otsuka America Pharmaceutical, Inc.$127
- AstraZeneca$88
- plus $706 from 16 others
What the payments were for
- Food & beverage$1,572100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 9 | $190 |
| Radius Health, Inc. | 6 | $178 |
| AbbVie | 7 | $142 |
| Boehringer Ingelheim | 6 | $140 |
| Otsuka America Pharmaceutical, Inc. | 6 | $127 |
| AstraZeneca | 4 | $88 |
| Amgen | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Lilly USA, LLC | 3 | $75 |
| Merck | 3 | $64 |
| Exact Sciences | 2 | $60 |
| Lundbeck LLC | 3 | $52 |
| Idorsia Pharmaceuticals US Inc | 2 | $45 |
| Dexcom, Inc. | 1 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Pfizer | 1 | $26 |
| Novartis | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| GSK | 1 | $16 |
How this compares
$1,572 in reported general payments places this provider in the 80th percentile of 706 primary care providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonidine | 11 | $1,347 |
| Rosuvastatin Calcium | 36 | $732 |
| Atorvastatin Calcium | 40 | $546 |
| Diclofenac Sodium | 13 | $402 |
| Losartan Potassium | 37 | $300 |
| Metoprolol Succinate | 19 | $281 |
| Hydralazine Hcl | 20 | $263 |
| Levothyroxine Sodium | 18 | $224 |
| Ezetimibe | 14 | $222 |
| Amlodipine Besylate | 35 | $167 |
| Lisinopril | 18 | $164 |
| Pantoprazole Sodium | 13 | $141 |
| Omeprazole | 18 | $111 |
| Metformin Hcl | 23 | $110 |
| Hydrochlorothiazide | 22 | $48 |
Paid to pharmacies, not to this prescriber.
Other primary care in Los Angeles
- Hamideh PourzandLos Angeles$103K
- Chanyoung KimLos Angeles$5K
- Lisa HsiehLos Angeles$4K
- Leslie FletcherTorrance$1.8M
- Veronica RamirezSacramento$83K
- Tyson FieldstedBakersfield$65K
- Joann BallPalm Desert$56K
- Kathryn CooperSan Diego$31K
- Shalaine Corbillala Mesa$22K
- Paula StoddardHanford$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.